Pharmaceutical and Life Sciences Law Archivos - Faus & Moliner Abogados

Faus Moliner participa en “International Comparative Legal Guide – Drug & Medical Device Litigation 2024”

Faus Moliner — Fri, 19 Apr 2024 10:11:28 +0000

The 2024 edition of the International International Comparative Legal Guide to Drug & Medical Device Litigation magazine is now available. The Guide offers a practical insight into drug and medical devices litigation issues across the world.

Xavier Moliner and Juan Martinez were in charge of chapter 15 dedicated to drug and medical device litigation.

La entrada Faus Moliner participa en “International Comparative Legal Guide – Drug & Medical Device Litigation 2024” aparece primero en Faus & Moliner Abogados.

Faus Moliner participates in “Chambers Global Practices Guides – Life Sciences 2024”

Juan Martínez — Tue, 16 Apr 2024 13:55:43 +0000

The Life Sciences 2024 guide features over 20 jurisdictions. The guide provides the latest legal information on challenging the decisions of regulatory bodies; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; pricing; digital healthcare; patents; and developments related to COVID-19.

La entrada Faus Moliner participates in “Chambers Global Practices Guides – Life Sciences 2024” aparece primero en Faus & Moliner Abogados.

Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2024”

Faus Moliner — Thu, 11 Apr 2024 10:20:04 +0000

The “Law & Practice” section provides easily accessible information on navigating the legal system when conducting business in the jurisdiction. Leading lawyers explain local law and practice at key transactional stages and for crucial aspects of doing business.

The “Trends and Developments” section analizes the latest trends and developments in connection with pharmaceutical advertising in Spain providing background information and relevant context when needed.

La entrada Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2024” aparece primero en Faus & Moliner Abogados.

Diez años de transparencia en España; ¿qué retos nos deparan los próximos años?

Faus Moliner — Wed, 31 Jan 2024 08:23:17 +0000

This article addresses the implications for the pharmaceutical sector of the application in Spain of Law 19/2013, of 9 December 2013, on transparency, access to public information and good governance, 10 years after its entry into force. In addition, the implications of the entry into force of the Tromsø Convention are analyzed. Finally, the challenges...

La entrada Diez años de transparencia en España; ¿qué retos nos deparan los próximos años? aparece primero en Faus & Moliner Abogados.

Pharma & Medical Device Regulation Spain 2024

Faus Moliner — Fri, 20 Oct 2023 10:18:39 +0000

Lexology has recently published the guide “Pharma & Medical Device Regulation Spain 2023” with contributions from Eduard Rodellar, Lluís Alcover, Juan Martínez, Anna Gerboles and Joan Carles Bailach.

This quick reference guide enables side-by-side comparison of local insights, including into the regulatory framework; clinical practice; marketing authorisation; amending authorisations; recall; promotion; enforcement of advertising rules; pricing and reimbursement; off-label use and unlicensed products; sale and supply; and recent trends in Spain.

La entrada Pharma & Medical Device Regulation Spain 2024 aparece primero en Faus & Moliner Abogados.

Global Legal Insights to: Pricing & Reimbursement 2023

Jordi Faus — Fri, 08 Sep 2023 09:29:46 +0000

The sixth edition of Pricing & Reimbursement has been recently published and just like last year Jordi Faus, with the collaboration of Lluís Alcover and Joan Carles Bailach, has been in charge of the chapter dedicated to pricing and reimbursement in Spain.

GLI Pricing & Reimbursement 2023 includes the following sections for each of the 18 analyzed countries:

Market overview;
Financing and pricing of medicinal products;
Policy issues that affect pricing and reimbursement; and
Emerging trends

La entrada Global Legal Insights to: Pricing & Reimbursement 2023 aparece primero en Faus & Moliner Abogados.

El medicamento en lo tribunales en el año 2022

Faus Moliner — Fri, 08 Sep 2023 09:08:40 +0000

By means of this article we go through the most important decisions by Spanish and
European courts regarding medicinal products during the year 2022.

La entrada El medicamento en lo tribunales en el año 2022 aparece primero en Faus & Moliner Abogados.

Faus Moliner participates in “Chambers Global Practices Guides Medical Cannabis & Cannabinoid Regulation 2023”

Faus Moliner — Tue, 27 Jun 2023 09:34:05 +0000

The guide on the regulation of medical cannabis and cannabinoids 2023 provides easily accessible content on the legal framework, cross-jurisdictional rules and future developments in the regulation of medical cannabis and cannabinoids in Spain.

La entrada Faus Moliner participates in “Chambers Global Practices Guides Medical Cannabis & Cannabinoid Regulation 2023” aparece primero en Faus & Moliner Abogados.

The Pharma Legal Handbook: Spain

Faus Moliner — Fri, 23 Jun 2023 08:52:27 +0000

The Pharma Legal Handbook is a guide that offers a practical view, in a question and answer format, to essential questions about the legal and regulatory environment applicable to medicinal products in Spain, in areas such as regulation, pricing and reimbursement, clinical trials, manufacturing, marketing and advertising of medicinal products, product liability and trademarks and...

La entrada The Pharma Legal Handbook: Spain aparece primero en Faus & Moliner Abogados.

Telemedicine: A global approach to trends and practices

Jordi Faus — Thu, 01 Jun 2023 15:31:15 +0000

This guide organized by the Healthcare and Life Sciences Law Committee covers the highly relevant topic of telemedicine across 54 countries offering practitioners and industry users easy access to the relevant applicable rules.

Each jurisdiction answers the most frequently raised questions in relation to telemedicine concerning regulation, data privacy, professional and product liability aspects, as well as recent developments and trends. Due to the rapid development and constant update of law and regulation in this field, each national report contains its date of conclusion for accuracy purposes.

La entrada Telemedicine: A global approach to trends and practices aparece primero en Faus & Moliner Abogados.